Talphera (TLPH) Other financing activities (2011 - 2026)
Talphera's (TLPH) quarterly Other financing activities came in at $4.0 million in Q1 2026, up 190.5% quarter-over-quarter from $1.4 million in Q4 2025.
Talphera (TLPH) Other financing activities (2011 - 2026) Analysis & Trends
Talphera's Other financing activities history runs 11 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $26.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $22.7 million, up 286.18% from the prior year.
- Other financing activities advanced to $4.0 million in Q1 2026 per TLPH's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other financing activities topped out at $17.0 million in Q3 2025 and bottomed at -$22000.0 in Q4 2023.
- The 5-year median for Other financing activities is $724000.0 (2022), against an average of $3.3 million.
- Across the five-year window, Other financing activities slumped 86.89% in 2022 and jumped 18880.65% in 2024, its largest moves.
- Year by year, Other financing activities stood at $16000.0 in 2022, then tumbled by 237.5% to -$22000.0 in 2023, then jumped by 26845.45% to $5.9 million in 2024, then slumped by 76.38% to $1.4 million in 2025, then surged by 190.5% to $4.0 million in 2026.
- Per Business Quant, the three latest TLPH Other financing activities figures stand at $4.0 million (Q1 2026), $1.4 million (Q4 2025), and $17.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.04 Mn |
| Mar 31, 2026 | 4.04 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 16.98 Mn |
| Sep 30, 2025 | 16.98 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | -22,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Mar 31, 2023 | 31,000.00 |
| Mar 31, 2023 | 31,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |